How have TRAW shares performed in 2024?

Traws Pharma's stock was trading at $0.8081 at the start of the year. Since then, TRAW stock has decreased by 19.6% and is now trading at $0.6499. View the best growth stocks for 2024 here .

When is Traws Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our TRAW earnings forecast .

How were Traws Pharma's earnings last quarter?

Traws Pharma, Inc. (NASDAQ:TRAW) posted its quarterly earnings data on Monday, April, 1st. The company reported ($0.20) earnings per share for the quarter. The firm had revenue of $0.06 million for the quarter. Traws Pharma had a negative trailing twelve-month return on equity of 113.18% and a negative net margin of 8,384.07%.

How do I buy shares of Traws Pharma?

Shares of TRAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:TRAW

Traws Pharma (TRAW) Stock Price, News & Analysis

→ Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad)

Free TRAW Stock Alerts

$0.64

+0.02 (+3.11%)

(As of 03:57 PM ET)

Compare

Today's Range: $0.61
▼
$0.66
50-Day Range: N/A
52-Week Range: $0.55
▼
$1.45

Volume: 24,124 shs
Average Volume: 108,989 shs
Market Capitalization: $13.44 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Earnings Financials Options Chain SEC Filings Social Media

Get Traws Pharma alerts:

Ad InvestorPlace

Elon’s New A.I. Device is About to Shock the World

Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”

Click here to see the details because there’s a lot of money at stake.

About Traws Pharma

Onconova Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecule drug candidates to treat cancer. The Company's products under different phases of development include Rigosertib intravenous (IV), Rigosertib Oral, Rigosertib IV, ON 013105 and Recilisib. Onconova Therapeutics, Inc. is headquartered in Newtown, Pennsylvania.

TRAW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TRAW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive TRAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Traws Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 4/01/2024
Today: 4/29/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:TRAW
CUSIP: N/A
CIK: 1130598
Web: www.onconova.com
Phone: 267-759-3680
Fax: 267-759-3681
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.91)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,950,000.00
Net Margins: -8,384.07%
Pretax Margin: -8,384.07%
Return on Equity: -113.18%
Return on Assets: -65.76%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.46
Quick Ratio: 2.46

Sales & Book Value

Annual Sales: $226,000.00
Price / Sales: 60.40
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.51 per share
Price / Book: 1.27

Miscellaneous

Outstanding Shares: 21,003,000
Free Float: 20,310,000
Market Cap: $13.65 million
Optionable: Optionable
Beta: 1.38

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Competitors

View All Competitors

TRAW Stock Analysis - Frequently Asked Questions

How have TRAW shares performed in 2024?: Traws Pharma's stock was trading at $0.8081 at the start of the year. Since then, TRAW stock has decreased by 19.6% and is now trading at $0.6499.
View the best growth stocks for 2024 here.
When is Traws Pharma's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our TRAW earnings forecast.
How were Traws Pharma's earnings last quarter?: Traws Pharma, Inc. (NASDAQ:TRAW) posted its quarterly earnings data on Monday, April, 1st. The company reported ($0.20) earnings per share for the quarter. The firm had revenue of $0.06 million for the quarter. Traws Pharma had a negative trailing twelve-month return on equity of 113.18% and a negative net margin of 8,384.07%.
How do I buy shares of Traws Pharma?: Shares of TRAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TRAW) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial